A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 6, 2010, Pages 1209-1220

  James, S Jill ^a   Melnyk, Stepan ^a   Jernigan, Stefanie ^a   Pavliv, Oleksandra ^a   Trusty, Timothy ^a   Lehman, Sara ^a   Seidel, Lisa ^a   Gaylor, David W ^b   Cleves, Mario A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

Autism; DNA methylation; Epigenetics; Maternal; Polymorphism; Reduced folate carrier

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE; DNA; HOMOCYSTEINE; REDUCED FOLATE CARRIER; S ADENOSYLHOMOCYSTEINE;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; LOGLINEAR MODEL; MAJOR CLINICAL STUDY; MOTHER; PRIORITY JOURNAL;

ADULT; ALLELES; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; EPIGENOMICS; FEMALE; FOLIC ACID; GENE FREQUENCY; HUMANS; MALE; MOTHERS; POLYMORPHISM, GENETIC; REDUCED FOLATE CARRIER PROTEIN; YOUNG ADULT;

EID: 77956111572     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31094     Document Type: Article

References (88)

1. Afman LA, Van der Put NMJ, Thomas CMG, Trijbels JMF, Blom HJ. 2001. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. Q J Med 94:159-166.
2. Allan AM, Liang X, Luo Y, Pak C, Li X, Szulwach KE, Chen D, Jin P, Zhao X. 2008. The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Hum Mol Genet 17:2047-2057.
3. Alonso-Aperte E, Ubeda N, Achon M, Perez-Miguelsanz J, Varela-Moreiras G. 1999. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 52:750-756.
4. Altevogt BM, Hanson SL, Leshner AI. 2008. Autism and the environment: Challenges and opportunities for research. Pediatrics 121:1225-1229.
5. Badcock C, Crespi B. 2006. Imbalanced genomic imprinting in brain development: An evolutionary basis for the aetiology of autism. J Evol Biol 19:1007-1032.
6. Bailey LB, Gregory JF III. 1999. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J Nutr 129:919-922.
7. Beaudin AE, Stover PJ. 2009. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: A minireview. Birth Defects Res A Clin Mol Teratol 85:274-284.
8. Bleich S, Frieling H, Hillemacher T. 2007. Elevated prenatal homocysteine levels and the risk of schizophrenia. Arch Gen Psychiatry 64:980-981.
9. Bosco P, Guéant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Guéant JL. 2003. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756AG/Methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet Part A 121A:219-224.
10. Brattström L, Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Cuskelly G, McNulty H, Strain SS, McPartlin J, Weir DG, Scott JM, Den Heijer M, Brouwer IA, Blom HJ, Bos GM, Spaans A, Rosendaal FR, Thomas CM, Haak HL, Wijermans PW, Gerrits WB, Naurath HJ, Joosten E. 1998. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. Br Med J 316:894-898.
11. Bukowski R, Malone FD, Porter FT, Nyberg DA, Comstock CH, Hankins GD, Eddleman K, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. 2009. Preconceptional folate supplementation and the risk of spontaneous preterm birth: A cohort study. PLoS Med 6:e1000061.
12. Burdge GC. 2006. Homocysteine: A role in fetal programming? Br J Nutr 96:415-417.
13. Buxbaum JD. 2009. Multiple rare variants in the etiology of autism spectrum disorders. Dialogues Clin Neurosci 11:35-43.
14. Cantor RM. 2009. Molecular genetics of autism. Curr Psychiatry Rep 11:137-142.
15. Castel-Dunwoody KM, Kauwell GP, Shelnutt KP, Vaughn JD, Griffin ER, Maneval DR, Theriaque DW, Bailey LB. 2005. Transcobalamin 776C->G polymorphism negatively affects vitamin B-12 metabolism. Am J Clin Nutr 81:1436-1441.
16. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, Santos-Guzman J, Swendseid ME, Cogger EA, James SJ. 2001. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine b-synthase heterozygous mice. J Nutr 131:2811-2818.
17. Chango A, Boisson F, Barbé F, Quilliot D, Droesch S, Pfister M, Fillon-Emery N, Lambert D, Frémont S, Rosenblatt DS, Nicolas JP. 2000a. The effect of 677C→T and 1298A→C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 83:593-596.
18. Chango A, Emery-Fillon N, De Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP. 2000b. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70:310-315.
19. Chen ZT, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SWM, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433-443.
20. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P, Rozen R. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157.
21. Cleves MA, Olson JM, Jacobs KB. 1997. Exact transmission-disequilibrium tests with multiallelic markers. Genet Epidemiol 14:337-347.
22. Cuco G, Fernandez-Ballart J, Sala J, Viladrich C, Iranzo R, Vila J, Arija V. 2006. Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr 60:364-371.
23. Davison JM, Mellott TJ, Kovacheva VP, Blusztajn JK. 2009. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes inrat fetal liver and brain. J Biol Chem 284:1982-1989.
24. De Bree A, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ. 2002. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 54:599-618.
25. Dolinoy DC, Huang D, Jirtle RL. 2007. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 104:13056-13061.
26. Doolin MT, Barbaux S, McDonnell M, Hoess K, Whitehead AS, Mitchell LE. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71:1222-1226.
27. Dror DK, Allen LH. 2008. Effect of vitamin B12 deficiency on neurodevelopment in infants: Current knowledge and possible mechanisms. Nutr Rev 66:250-255.
28. Dufficy L, Naumovski N, Ng X, Blades B, Yates Z, Travers C, Lewis P, Sturm J, Veysey M, Roach PD, Lucock MD. 2006. G80A reduced folate carrier SNP influences the absorption and cellular translocation of dietary folate and its association with blood pressure in an elderly population. Life Sci 79:957-966.
29. Dunlevy LP, Burren KA, Mills K, Chitty LS, Copp AJ, Greene ND. 2006. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol 76:544-552.
30. Friedman G, Goldschmidt N, Friedlander Y, Ben Yehuda A, Selhub J, Babaey S, Mendel M, Kidron H, Bar-On M. 1999. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations. J Nutr 129:1656-1661.
31. Friso S, Choi SW, Dolnikowski GG, Selhub J. 2002a. A method to assess genomic DNA methylation using high-performance liquid chromatography/ electrospray ionization mass spectrometry. Anal Chem 74:4526-4531.
32. Friso S, Choi SW, Dolnikowski GG, Selhub J. 2002b. A method to assess genomic DNA methylation using high-performance liquid chromatography/ electrospray ionization mass spectrometry. Anal Chem 74:4526-4531.
33. Furness DL, Fenech MF, Khong YT, Romero R, Dekker GA. 2008. One-carbon metabolism enzyme polymorphisms and uteroplacental insufficiency. Am J Obstet Gynecol 199:276-278.
34. Gaughan DJ, Kluijtmans LAJ, Barbaux S, McMaster D, Young IS, Yarnell JWG, Evans A, Whitehead AS. 2001. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157:451-456.
35. Gellekink H, Blom HJ, Den Heijer M. 2007. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk. Clin Chem Lab Med 45:471-476.
36. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H. 2009. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569-573.
37. Hishida R, Nau H. 1998. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione. Teratog Carcinog Mutagen 18:49-61.
38. Hobbs CA, Cleves MA, Melnyk S, Zhao W, James SJ. 2005. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 81:147-153.
39. Isotalo PA, Wells GA, Donnelly JG. 2000. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am J Hum Genet 67:986-990.
40. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, Henning SM, Swendseid ME. 1998. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 128:1204-1212.
41. James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. 1999. Abnormal folate metabolism and mutation in the methylenetetrahyrofolate reductase (MTHFR) gene may be maternal risk factors for Down Syndrome. Am J Clin Nutr 70:495-501.
42. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. 2002. Elevation in S-adenosylhomocysteine and DNA hypomethylation: Potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132:2361S-2366S.
43. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW. 2006. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet Part B 141B:947-956.
44. James SJ, Melnyk S, Jernigan S, hubanks A, Rose S, Gaylor DW. 2009. Abnormal transmethylation/transsulfuration metaboism and DNA hypomethylation among parents of children with autism. J Autism Dev Disord 38:1976-1980.
45. Jiang YH, Sahoo T, Michaelis RC, Bercovich D, Bressler J, Kashork CD, Liu Q, Shaffer LG, Schroer RJ, Stockton DW, Spielman RS, Stevenson RE, Beaud AL, et al. 2004. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet Part A 131A:1-10.
46. Johnson WG. 1999. DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders. Am J Med Genet 88:311-323.
47. Johnson WG. 2003a. Teratogenic alleles and neurodevelopmental disorders. BioEssays 25:464-477.
48. Johnson WG. 2003b. Teratogenic alleles and neurodevelopmental disorders. BioEssays 25:464-477.
49. Johnson WG, Sreenath M, Buyske S, Stenroos ES. 2008. Teratogenic alleles in Autism and other neurodevelopmental disorders. In: Zimmerman AW,editor. Autism: Current theories and evidence. Toweta, NJ:Humana Press/Springer. pp 41-48.
50. Johnson WG, Buyske S, Mars AE, Sreenath M, Stenroos ES, Williams TA, Stein R, Lambert GH. 2009. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch Pediatr Adolesc Med 163:542-546.
51. Kempisty B, Sikora J, Lianeri M, Szczepankiewicz A, Czerski P, Hauser J, Jagodzinski PP. 2007. MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia. Psychiatr Genet 17:177-181.
52. Kramer MS, Kahn SR, Rozen R, Evans R, Platt RW, Chen MF, Goulet L, Seguin L, Dassa C, Lydon J, McNamara H, Dahhou M, Genest J. 2009. Vasculopathic and thrombophilic risk factors for spontaneous preterm birth. Int J Epidemiol 38:715-723.
53. Lazzerini PE, Capecchi PL, Selvi E, Lorenzini S, Bisogno S, Galeazzi M, Laghi PF. 2007. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun Rev 6:503-509.
54. Lee LC, Zachary AA, Leffell MS, Newschaffer CJ, Matteson KJ, Tyler JD, Zimmerman AW. 2006. HLA-DR4 in families with autism. Pediatr Neurol 35:303-307.
55. Lim MA, Stack CM, Cuasay K, Stone MM, McFarlane HG, Waschek JA, Hill JM. 2008. Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior. Int J Dev Neurosci 26:423-434.
56. Lopreato FR, Stabler SP, Carvalho FR, Hirata RD, Hirata MH, Robi DL, Sampaio-Neto LF, Allen RH, Guerra-Shinohara EM. 2008. Relationships between gene polymorphisms of folate-related proteins and vitamins and metabolites in pregnant women and neonates. Clin Chim Acta 398:134-139.
57. Mansoor MA, Kristensen O, Hervig T, Bates CJ, Pentieva K, Vefring H, Osland A, Berge T, Drablos PA, Hetland O, Rolfsen S. 1999. Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate. Scand J Clin Lab Invest 59:139-146.
58. Mattson MP, Shea TB. 2003. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137-146.
59. McKeever M, Molloy A, Weir DG, Young PB, Kennedy DG, Kennedy S, Scott JM. 1995. An abnormal methylation ratio induces hypomethylation in vitro in the brain of pig and man, but not in rat. Clin Sci (Colch) 88:73-79.
60. Melnyk S, Pogribna M, Pogribny I, Hine RJ, James SJ. 1999. A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection. J Nutr Biochem 10:490-497.
61. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. 2000. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: Alterations with plasma homocysteine and pyridoxal 50-phosphate concentrations. Clin Chem 46:265-272.
62. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. 2006. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1:172-182.
63. NCBI. Database. http://www.ncbi.nlm.nih.gov/SNP/snp-ref.cgi?rs=1051266. 2009.
64. Niculescu MD, Zeisel SH. 2002. Diet, methyl donors and DNA methylation: Interactions between dietary folate, methionine and choline. J Nutr 132:2333S-2335S.
65. Niculescu MD, Craciunescu CN, Zeisel SH. 2006. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J 20:43-49.
66. O'Leary VB, Pangilinan F, Cox C, Parle-McDermott A, Conley M, Molloy AM, Kirke PN, Mills JL, Brody LC, Scott JM. 2006. Reduced folate carrier polymorphisms and neural tube defect risk. Mol Genet Metab 87:364-369.
67. Pei LJ, Li ZW, Zhang W, Ren AG, Zhu HP, Hao L, Zhu JH, Li Z. 2005a. Epidemiological study on reduced folate carrier gene(RFC1 A80G) polymorphism and other risk factors of neural tube defects. Beijing Da Xue Xue Bao 37:341-345.
68. Pei LJ, Zhu HP, Li ZW, Zhang W, Ren AG, Zhu JH, Li Z. 2005b. Interaction between maternal periconceptional supplementation of folic acid and reduced folate carrier gene polymorphism of neural tube defects. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22: 284-287.
69. Pickard B, Dean W, Engemann S, Bergmann K, Fuermann M, Jung M, Reis A, Allen N, Reik W, Walter J. 2001. Epigenetic targeting in the mouse zygote marks DNA for later methylation: A mechanism for maternal effects in development. Mech Dev 103:35-47.
70. Picker JD, Coyle JT. 2005. Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? Harv Rev Psychiatry 13:197-205.
71. Prescott SL, Clifton V. 2009. Asthma and pregnancy: Emerging evidence of epigenetic interactions in utero. Curr Opin Allergy Clin Immunol 9:417-426.
72. Reik W. 2007. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447:425-432.
73. Reik W, Dean W. 2001. DNA methylation and mammalian epigenetics. Electrophoresis 22:2838-2843.
74. Samaco RC, Hogart A, LaSalle JM. 2005. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14:483-492.
75. Schanen NC. 2006. Epigenetics of autism spectrum disorders. Hum Mol Genet 15(SpecNo 2): R138-R150.
76. Scholl TO, Johnson WG. 2000. Folic acid: Influence on the outcome of pregnancy. Am J Clin Nutr 71:1295S-1303S.
77. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
78. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J. 1998. Schizophrenia and impaired homocysteine metabolism: A possible association. Biol Psychiatry 44:141-143.
79. van der Linden I, Afman LA, Heil SG, Blom HJ. 2006. Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc 65:204-215.
80. van der Linden I, Heil SG, van Egmont PM, van Straaten HW, Den Heijer M, Blom HJ. 2008. Inhibition of methylation and changes in gene expression in relation to neural tube defects. Birth Defects Res A Clin Mol Teratol 82:676-683.
81. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. 1999. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 180:660-664.
82. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: Assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62:969-978.
83. Wilcox AJ, Weinberg CR, Lie RT. 1998. Distinguishing the effects of maternal and offspring genes through studies of "case-parent triads". Am J Epidemiol 148:893-901.
84. Williams TA, Mars AE, Buyske SG, Stenroos ES, Wang R, Factura-Santiago MF, Lambert GH, Johnson WG. 2007. Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. Arch Pediatr Adolesc Med 161:356-361.
85. Yates Z, Lucock M. 2005. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. Life Sci 77:2735-2742.
86. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hines RJ, James SJ. 2000. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318-29323.
87. Zeisel SH. 2009a. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr 89:1488S-1493S.
88. Zeisel SH. 2009b. Importance of methyl donors during reproduction. Am J Clin Nutr 89:673S-677S.